Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,137
+$634 QoQ
Shares Held
84
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#459
of 626 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CNB Bank holds $13,085,387 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,526 | $3,655,322 | |
| 2 | MRK |
Merck & Co., Inc.
|
22,166 | $2,848,330 | |
| 3 | LLY |
ELI LILLY & Co
|
1,946 | $2,334,090 | |
| 4 | JNJ |
Johnson & Johnson
|
7,372 | $1,872,266 | |
| 5 | PFE |
Pfizer Inc
|
44,289 | $1,066,478 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,647 | $382,999 | |
| 7 | NVS |
Novartis AG
|
2,220 | $347,918 | |
| 8 | AMGN |
Amgen Inc
|
809 | $292,955 |
All Filings in OGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,137 | 84 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $503 | 84 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $602 | 84 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $897 | 84 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $619 | 64 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $952 | 64 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $954 | 64 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,224 | 64 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,324 | 64 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,203 | 64 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $922 | 64 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,111 | 64 | Shares | Sole | 2023-11-02 | |
| 2021-06-30 | $2,723 | 90 | Shares | Sole | 2021-07-29 | |
| No filing history on record for this holder in this stock. | ||||||